Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1952 5
1953 3
1954 2
1955 4
1956 1
1957 5
1958 3
1959 4
1960 1
1961 5
1962 8
1963 4
1964 4
1965 4
1966 8
1967 9
1968 17
1969 21
1970 19
1971 22
1972 27
1973 24
1974 34
1975 26
1976 12
1977 14
1978 20
1979 15
1980 21
1981 20
1982 22
1983 34
1984 28
1985 28
1986 32
1987 35
1988 37
1989 47
1990 38
1991 45
1992 62
1993 72
1994 70
1995 53
1996 93
1997 94
1998 77
1999 95
2000 107
2001 90
2002 107
2003 99
2004 88
2005 120
2006 107
2007 141
2008 139
2009 126
2010 142
2011 159
2012 158
2013 167
2014 174
2015 165
2016 170
2017 137
2018 130
2019 161
2020 173
2021 182
2022 156
2023 150
2024 187
2025 191
2026 127

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,724 results

Results by year

Filters applied: . Clear all
Page 1
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.
Kudo M, Aoki T, Ueshima K, Tsuchiya K, Morita M, Chishina H, Takita M, Hagiwara S, Minami Y, Ida H, Nishida N, Ogawa C, Tomonari T, Nakamura N, Kuroda H, Takebe A, Takeyama Y, Hidaka M, Eguchi S, Chan SL, Kurosaki M, Izumi N. Kudo M, et al. Among authors: aoki t. Liver Cancer. 2023 Feb 7;12(4):321-338. doi: 10.1159/000529574. eCollection 2023 Sep. Liver Cancer. 2023. PMID: 37901197 Free PMC article.
Channel synapse mediates neurotransmission of airway protective chemoreflexes.
Soma S, Hayatsu N, Nomura K, Sherwood MW, Murakami T, Sugiyama Y, Suematsu N, Aoki T, Yamada Y, Asayama M, Kaneko M, Ohbayashi K, Arizono M, Ohtsuka M, Hamada S, Matsumoto I, Iwasaki Y, Ohno N, Okazaki Y, Taruno A. Soma S, et al. Among authors: aoki t. Cell. 2025 May 15;188(10):2687-2704.e29. doi: 10.1016/j.cell.2025.03.007. Epub 2025 Apr 4. Cell. 2025. PMID: 40187347 Free article.
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.
Sarkozy C, Wu S, Takata K, Aoki T, Neriah SB, Milne K, Goodyear T, Strong C, Rastogi T, Hilton LK, Lai D, Sehn LH, Farinha P, Nelson BH, Weng A, Marra M, Scott DW, Craig JW, Steidl C, Roth A. Sarkozy C, et al. Among authors: aoki t. Cancer Cell. 2024 Jun 10;42(6):1003-1017.e6. doi: 10.1016/j.ccell.2024.05.011. Cancer Cell. 2024. PMID: 38861923 Free article.
Multidisciplinary treatment for advanced gastric cancer.
Kanaji S, Urakawa N, Harada H, Ikeda T, Koterazawa Y, Aoki T, Sawada R, Otowa Y, Goto H, Hasegawa H, Yamashita K, Matsuda T, Kakeji Y. Kanaji S, et al. Among authors: aoki t. Int J Clin Oncol. 2025 Jul;30(7):1268-1275. doi: 10.1007/s10147-025-02792-4. Epub 2025 May 29. Int J Clin Oncol. 2025. PMID: 40439973 Review.
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.
Aoki T, Jiang A, Xu A, Yin Y, Gamboa A, Milne K, Takata K, Miyata-Takata T, Chung S, Rai S, Wu S, Warren M, Strong C, Goodyear T, Morris K, Chong LC, Hav M, Colombo AR, Telenius A, Boyle M, Ben-Neriah S, Power M, Gerrie AS, Weng AP, Karsan A, Roth A, Farinha P, Scott DW, Savage KJ, Nelson BH, Merchant A, Steidl C. Aoki T, et al. J Clin Oncol. 2024 Mar 20;42(9):1077-1087. doi: 10.1200/JCO.23.01115. Epub 2023 Dec 19. J Clin Oncol. 2024. PMID: 38113419 Free PMC article.
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study.
Aoki T, Kudo M, Nishida N, Ueshima K, Tsuchiya K, Tada T, Morita M, Chishina H, Takita M, Hagiwara S, Ida H, Minami Y, Kuroda H, Nakamura N, Hiraoka A, Tomonari T, Tani J, Naganuma A, Kakizaki S, Ogawa C, Hatanaka T, Ishikawa T, Kawata K, Takebe A, Matsumoto I, Hidaka M, Kurosaki M, Kumada T, Izumi N. Aoki T, et al. J Gastroenterol. 2025 Jun;60(6):738-753. doi: 10.1007/s00535-025-02233-z. Epub 2025 Mar 7. J Gastroenterol. 2025. PMID: 40055288 Free PMC article.
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.
Vitale A, Kim JS, Cabibbo G, Casadei-Gardini A, Iavarone M, Rimassa L, Ponziani FR, Tovoli F, Chon HJ, Kang B, Kim C, Imaoka H, Ikeda M, Kudo M, Aoki T, Tortora R, Guarracino M, Stefanini B, Marseglia M, Sparacino A, Celsa C, Bruccoleri M, Alimenti E, Marra F, Campani C, Bhoori S, Mazzaferro V, Sacco R, Facciorusso A, Martini A, Stella L, Cerrito L, Toyoda H, Yasuda S, Rossari F, Rimini M, Suda G, Sho T, Masi G, Vivaldi C, Pressiani T, Kakizaki S, Naganuma A, Avallone A, Nappi A, Vidili G, Soldà C, Bergamo F, Pinato DJ, Pelizzaro F, Foschi FG, Secomandi A, Verderame F, Bronte E, Martinelli E, Marino D, Grasselli S, Olivani A, Brunetto MR, Damone F, Mega A, Marzi L, Tamburini E, Ramundo M, Federico P, Daniele B, Giannini EG, Pasta A, Morisco F, Guarino M, Hoyek C, Boninsegna S, Gupta A, Sacerdoti D, Dalbeni A, Calvo Ramos I, Adeva J, Saitta C, Pitrone C, Lentini Graziano ML, Farella N, Rendina M, Grassi T, Rodriquenz MG, Maiello E, Presa J, Pinho I, Hiasa Y, Hirooka M, Chen J, Arrichiello G, Aschele C, Furlanetto A, Cillo U. Vitale A, et al. Among authors: aoki t. Liver Cancer. 2025 Aug 5. doi: 10.1159/000547792. Online ahead of print. Liver Cancer. 2025. PMID: 41063731 Free PMC article.
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.
Rai S, Duns G, Frontzek F, Wong JCH, Yin Y, Li MY, Kishida M, Fujisawa M, Healy S, Viganò E, Jiang A, Woolcock B, Telenius A, Ben-Neriah S, Meissner B, Boyle M, Nakamura H, O'Brien L, Cassidy C, Lytle A, Farinha P, Slack G, Hilton LK, Morin RD, Venturutti L, Aoki T, Wretham N, Bush JW, Evgin L, Savage KJ, Scott DW, Steidl C. Rai S, et al. Among authors: aoki t. Blood. 2025 Sep 25;146(13):1586-1600. doi: 10.1182/blood.2025028412. Blood. 2025. PMID: 40540746
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.
Sarkozy C, Wu S, Takata K, Aoki T, Neriah SB, Milne K, Goodyear T, Strong C, Rastogi T, Hilton LK, Lai D, Sehn LH, Farinha P, Nelson BH, Weng A, Marra M, Scott DW, Craig JW, Steidl C, Roth A. Sarkozy C, et al. Among authors: aoki t. Cancer Cell. 2024 Sep 9;42(9):1630. doi: 10.1016/j.ccell.2024.07.012. Epub 2024 Aug 15. Cancer Cell. 2024. PMID: 39151424 Free article. No abstract available.
4,724 results